A Randomized, Double-blind, Multicenter Phase III Clinical Study of Docetaxel for Injection (Albumin Bound) Combined With Best Supportive Care Versus Placebo Plus Best Supportive Care in Advanced Pancreatic Cancer
Latest Information Update: 18 Jul 2024
At a glance
- Drugs Docetaxel (Primary)
- Indications Pancreatic cancer
- Focus Registrational; Therapeutic Use
- Sponsors CSPC ZhongQi Pharmaceutical Technology
Most Recent Events
- 18 Jul 2024 New trial record